TD Waterhouse Canada Inc. raised its holdings in shares of OR Royalties Inc. (NYSE:OR – Free Report) by 7.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 222,884 shares of the basic materials company’s stock after purchasing an additional 15,149 shares during the period. TD Waterhouse Canada Inc. owned about 0.12% of OR Royalties worth $8,916,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of OR. Goldman Sachs Group Inc. raised its stake in OR Royalties by 152.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,256,583 shares of the basic materials company’s stock worth $26,539,000 after acquiring an additional 758,815 shares during the period. Synergy Asset Management LLC grew its holdings in shares of OR Royalties by 23.5% during the second quarter. Synergy Asset Management LLC now owns 17,617 shares of the basic materials company’s stock valued at $453,000 after purchasing an additional 3,347 shares during the last quarter. Louisbourg Investments Inc. raised its position in shares of OR Royalties by 24.8% during the 2nd quarter. Louisbourg Investments Inc. now owns 348,831 shares of the basic materials company’s stock worth $8,949,000 after purchasing an additional 69,276 shares during the period. U S Global Investors Inc. raised its position in shares of OR Royalties by 6.3% during the 2nd quarter. U S Global Investors Inc. now owns 574,831 shares of the basic materials company’s stock worth $14,781,000 after purchasing an additional 33,854 shares during the period. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of OR Royalties by 0.5% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 283,500 shares of the basic materials company’s stock worth $7,291,000 after purchasing an additional 1,500 shares during the last quarter. 68.52% of the stock is currently owned by institutional investors.
OR Royalties Trading Down 2.4%
OR Royalties stock opened at $45.69 on Friday. OR Royalties Inc. has a 52 week low of $17.55 and a 52 week high of $47.75. The stock has a market cap of $8.55 billion, a price-to-earnings ratio of 57.83 and a beta of 0.78. The company’s 50-day moving average price is $37.69 and its two-hundred day moving average price is $34.69.
OR Royalties Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st were paid a $0.055 dividend. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Wednesday, December 31st. OR Royalties’s payout ratio is currently 27.85%.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Wall Street Zen raised OR Royalties from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 19th. Weiss Ratings restated a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. Canaccord Genuity Group upgraded shares of OR Royalties from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 22nd. Raymond James Financial raised shares of OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price for the company in a research note on Thursday, November 6th. Finally, Scotiabank raised their price target on shares of OR Royalties from $41.00 to $51.00 and gave the company a “sector perform” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $38.25.
Check Out Our Latest Analysis on OR Royalties
OR Royalties Profile
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Featured Stories
- Five stocks we like better than OR Royalties
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Buy this Gold Stock Before May 2026
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
